1Marik PE. Aspiration pneumonitis and aspiration pneumonia[J]. N Engl J Med,2001, 344:665-671.
2Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate ini- tial treatment for aspiration pneumonia? A prospective evaluationusing a protected specimen brush and quantitative cultures [ J ]. In- tensive Care Med, 1993,19:279-284.
3Marik PE, Careau P. The role of anaerobes in patients with ventilato- rassociated pneumonia and aspiration pneumonia: a prospective study [ J]. Chest,1999,115:178-183.
6Katzap E, Barilla-l.aBarca ML, Marder G. Antisynthetase syndrome [J]. Curt Rheumatol Rep,2011,13(3) :175-181.
7Labirua A, lamdberg IE. Interstitial lung disease and idiopathic in- flammatory myopathies: progress and pilfalls [ J ]. Curt Opin Rbeu- matol,2010, 22 ( 6 ) :633-638.
8Joshua S,Jeffrey JS, Kevin KB. Myositis-related interstitial lung dis- ease and anti-synthetase syndrome [ J ]. J Bras Pneumol, 2011,37 (1) :100-109.
9Richards T J, Eggebeen A,Gibson K, et al. Characterization and pe-ripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease [ J ]. Arthritis Rheum, 2009,60 ( 7 ) : 2183 - 2192.
10Emeline GM, Nicole F, Jean-Francois C, et al. Clinical significance of Anti-Histidyl-tRNA Synthetasc ( Jol ) autoantibodies [ J ]. New York Academy of Science,2007(1109) :414-420.
